ImmunityBio (IBRX) Cash & Equivalents Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 67.78% |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | 238.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 238.27% |
| Dec 31, 2025 | -38.41% |
| Sep 30, 2025 | -46.20% |
| Jun 30, 2025 | 5.81% |
| Mar 31, 2025 | -54.40% |
| Dec 31, 2024 | -45.97% |
| Sep 30, 2024 | -37.08% |
| Jun 30, 2024 | 199.05% |
| Mar 31, 2024 | 50.35% |
| Dec 31, 2023 | 153.68% |
| Sep 30, 2023 | 70.85% |
| Jun 30, 2023 | -29.72% |
| Mar 31, 2023 | 143.18% |
| Dec 31, 2022 | -42.22% |
| Sep 30, 2022 | 61.43% |
| Jun 30, 2022 | -26.27% |
| Mar 31, 2022 | -18.56% |
| Dec 31, 2021 | 418.69% |
| Sep 30, 2021 | -23.81% |
| Jun 30, 2021 | -27.10% |
| Mar 31, 2021 | -23.83% |
| Dec 31, 2020 | -53.94% |
| Sep 30, 2020 | 362.99% |
| Jun 30, 2020 | 566.49% |
| Mar 31, 2020 | 163.27% |
| Dec 31, 2019 | 350.63% |
| Sep 30, 2019 | 19.47% |
| Jun 30, 2019 | 7.18% |
| Mar 31, 2019 | 98.99% |
| Dec 31, 2018 | -29.54% |
| Sep 30, 2018 | -5.04% |
| Jun 30, 2018 | -58.70% |
| Mar 31, 2018 | -17.65% |
| Dec 31, 2017 | 195.34% |
| Sep 30, 2017 | -48.66% |
| Jun 30, 2017 | 2.13% |
| Mar 31, 2017 | -78.50% |
| Dec 31, 2016 | -95.40% |
| Sep 30, 2016 | -91.24% |
| Jun 30, 2016 | -68.26% |
| Mar 31, 2016 | 26.87% |
| Dec 31, 2015 | 197.62% |
| Sep 30, 2015 | 11,180.78% |
| Jun 30, 2015 | 2,916.96% |
| Dec 31, 2014 | 16,786.86% |